Medium Biosciences
Focus: Medium Biosciences is an AI-driven protein therapeutics company headquartered in San Francisco, leveraging computational design to develop novel protein-based treatments. The company operates as a pre-revenue or early-stage biotech with limited public financial disclosure.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Medium Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Medium Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
The domestic PCA equipment 'Accufuser Omnibus®'
Upper Gastrointestinal CancerClinical Trials (1)
NCT01976494The Efficacy and Safety of Accufuser Omnibus® (Elastomeric Infusion Pump); Comparative Clinical Trial
N/AHelp build intelligence for Medium Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.